Shulman De Meo Asset Management LLC Incyte Corp Transaction History

Shulman De Meo Asset Management LLC

  • $406 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 27, 2022
BUY
$66.02 - $79.71 $178,848 - $215,934
2,709 New
2,709 $215,000
Q3 2021

Oct 26, 2021
SELL
$68.67 - $84.02 $190,353 - $232,903
-2,772 Closed
0 $0
Q2 2021

Jul 21, 2021
BUY
$79.87 - $87.53 $221,399 - $242,633
2,772 New
2,772 $233,000
Q4 2020

Jan 13, 2021
SELL
$80.74 - $97.7 $216,221 - $261,640
-2,678 Closed
0 $0
Q3 2020

Nov 02, 2020
BUY
$85.07 - $109.69 $227,817 - $293,749
2,678 New
2,678 $240,000

Others Institutions Holding INCY

# of Institutions
644
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Shulman De Meo Asset Management LLC Portfolio

Follow Shulman De Meo Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shulman De Meo Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shulman De Meo Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email